IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy

European Journal of Haematology

Volumn 90, Issue 3, 2013, Pages 250-256

  Wong, Patrick C W ^a   Fung, Adrian T ^a   Gerrie, Alina S ^a   Moloney, Gregory ^a   Maberley, David ^a   Rossman, David ^a   White, Valerie ^a   Collins, David ^a   Coupland, Robert ^a   Chen, Luke Y C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Eosinophilia; Fludarabine; IgG4, hypergammaglobulinemia; IgG4 related disease; Retinal hemorrhage; Rituximab; Vasculitis; Viscosity

Indexed keywords

FLUDARABINE; IMMUNOGLOBULIN G4; PREDNISONE; RITUXIMAB;

ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CERVICAL LYMPH NODE; CORONARY ARTERY ANEURYSM; DRUG RESPONSE; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOHISTOCHEMISTRY; LACRIMAL GLAND; LYMPH NODE BIOPSY; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINOPATHY; SYMPTOM;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; DRUG THERAPY, COMBINATION; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; LACRIMAL APPARATUS; LYMPH NODES; LYMPHATIC DISEASES; MALE; RETINAL DEGENERATION; VASCULITIS; VIDARABINE;

EID: 84873988360     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12059     Document Type: Article

References (25)

1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012;366(6):539-51.
2. Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 2010;17(5):303-32.
3. Khosroshahi A, Deshpande V, Stone JH. The Clinical and Pathological Features of IgG4-Related Disease. Curr Rheumatol Rep 2011;13(6):473-81.
4. Aalberse RC, Van Milligen F, Tan KY, Stapel SO. Allergen-specific IgG4 in atopic disease. Allergy 1993;48(8):559-69.
5. Hussain R, Poindexter RW, Ottesen EA. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J Immunol 1992;148(9):2731-7.
6. Ishida F, Kitano K, Kobayashi H, Saito H, Kiyosawa K. Elevated IgG4 levels in a case with multicentric Castleman's disease. Br J Haematol 1997;99(4):981-2.
7. Dispenzieri A, Gertz MA, Therneau TM, Kyle RA. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc 2001;76(5):476-87.
8. Amati F, Canellini G, Beris P. Polyclonal hypergammaglobulinaemia with hyperviscosity syndrome. Br J Haematol 2002;116(1):2.
9. Chen LY, Lai EJ, Collins DR, Ostrow DN, Sreenivasan GM. A young woman with episodic angioedema, papilledema, and eosinophilia. Am J Hematol 2009;85(2):124-7.
10. Bach LA, Buchanan RR, Scarlett JD, Fraser KJ. Hyperviscosity syndrome secondary to rheumatoid arthritis. Aust N Z J Med 1989;19(6):710-12.
11. Simon JA, Lazo-Langner A, Duarte-Rojo A, Velázquez-González A, Sánchez-Guerrero SA, Sánchez-Guerrero J. Serum hyperviscosity syndrome responding to therapeutic plasmapheresis in a patient with primary Sjögren's syndrome. J Clin Apher 2002;17(1):44-6.
12. Boulanger E, Fuentes V, Meignin V, et al. Polyclonal IgG4 hypergammaglobulinemia associated with plasmacytic lymphadenopathy, anemia and nephropathy. Ann Hematol 2006;85(12):833-40.
13. Matsumoto Y, Kasashima S, Kawashima A, Sasaki H, Endo M, Kawakami K, Zen Y, Nakanuma Y. A case of multiple immunoglobulin G4-related periarteritis: a tumorous lesion of the coronary artery and abdominal aortic aneurysm. Hum Pathol 2008;39(6):975-80.
14. Miller DV, Maleszewski JJ. The pathology of large-vessel vasculitides. Clin Exp Rheumatol 2011;1(Suppl 64):S92-8.
15. Sato Y, Ohshima K, Ichimura K, Sato M, Yamadori I, Tanaka T, Takata K, Morito T, Kondo E, Yoshino T. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int 2008;58(8):465-70.
16. Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Küttner's tumor). Am J Surg Pathol 2005;29(6):783-91.
17. Karamchandani JR, Younes SF, Warnke RA, Natkunam Y. IgG4-related systemic sclerosing disease of the ocular adnexa. Am J Clin Pathol 2012;137:699-711.
18. Deshpande V, Zen Y, Chan J, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012;25:1181-92.
19. Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010;62(6):1755-62.
20. Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 2012;91(1):57-66.
21. Khan ML, Colby TV, Viggiano RW, Fonseca R. Treatment with bortezomib of a patient having hyper IgG4 disease. Clin Lymphoma Myeloma Leuk 2010;10(3):217-19.
22. Takada K, Danning CL, Kuroiwa T, Schlimgen R, Tassiulas IO, Davis JC Jr, Yarboro CH, Fleisher TA, Boumpas DT, Illei GG. Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects. Ann Rheum Dis 2003;62:1112-15.
23. Goodman ER, Fledor PS, Fein S, Athan E, Hardy MA. Fludarabine phosphate: a DNA synthesis inhibitor with potent immunosuppressive activity and minimal clinical toxicity. Am Surg 1996;62(6):435-42.
24. Di Gaetano N, Xiao Y, Erba E, Bassan R, Rambaldi A, Golay J, Introna M. Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone. Br J Haematol 2001;114:800-9.
25. Gerrie AS, Toze CL, Ramadan KM, Li CH, Sutherland J, Yee A, Connors JM. Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials. Leuk Lymphoma 2012;53(1):77-82.